GRCL (Gracell Biotechnologies) Kacepetan wutah bathi saben saham ing taun lumaku

Through its integration with AstraZeneca, Gracell Biotechnologies (GRCL) has retained its key scientific staff, preventing brain drain. This is bolstered by the company's own cGMP facilities in the US and China, which guarantee autonomous drug production. The business relies on breakthroughs in CAR-T therapy, remaining insulated from economic cycles. The annual earnings per share trajectory illustrates these successes, and the parameter has stabilized at 0.00.

GRCL: Wutah bathi saben saham ing taun lumaku Gracell Bio 04.07.2022 - 03.03.2024

Rincian metrik keuangan lan pasar Gracell Biotechnologies (GRCL)

- rega lan prakiraan konsensus rega:

Kutipan saham Gracell Bio|GRCL - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Nilai pasar Gracell|GRCL - Nilai Total Perusahaan

- data ekuitas miturut neraca:

Aset Bersih saben Siji Saham Gracell Biotechnologies|GRCL - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku gracellbio.com|GRCL - Gunggung Aset Perusahaan

- rincian utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Gracell Biotechnologies|GRCL - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas gracellbio.com|GRCL - Gunggung utang perusahaan|Utang-utang marang nilai buku Gracell|GRCL - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Gracell Biotechnologies|Likuiditas darurat gracellbio.com

- informasi bathi lan kelipatan valuasi:

GRCL - Penghasilan resik|Penghasilan resik sing dikarepake Gracell Biotechnologies|GRCL - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Gracell|GRCL - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Gracell|GRCL - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Gracell Biotechnologies|GRCL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan gracellbio.com|GRCL - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Gracell Biotechnologies

- data pendapatan lan penerimaan dodolan:

GRCL - Pendapatan perusahaan|Pendapatan sing dikarepake perusahaan Gracell Bio|GRCL - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Gracell

Pambiji fundamental:GRCL Gracell Bio

Produk sing diprodhuksi Gracell Biotechnologies

Gracell Biotechnologies (GRCL) innovations in affordable cell therapy require colossal expenditures, which directly impacts yield dynamics. By analyzing the year-over-year (YoY) change in net income per share, an investor can observe the growth or decline rates of EPS relative to the previous year. This indicator measures the efficiency of business capitalization, allowing for the determination of the fair value of shares for this high-risk biotechnological asset.

Pesaing utama

Wutah bathi resik saben saham ing taun iki Legend Biotech Corp|SANA (Sana Bio) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Autolus Corp AUTL|Wutah bathi saben saham ing taun lumaku Allogene Therapeutics (ALLO)|Wutah bathi saben saham ing taun lumaku RNAC (selectabio.com)|Wutah bathi saben saham ing taun lumaku Cellectis CLLS|Caribou Biosciences Inc. - Wutah bathi saben saham ing taun lumaku|TIL: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku GNTA (Genenta Science S.p.A.)|IPSC: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Jasper Therapeutics, Inc. JSPR|SNTI (Senti Bio) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Adaptimmune Therapeutics PLC ADAP|Wutah bathi saben saham ing taun lumaku CERo Therapeutics (CERO)|alaunos.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku ACHL (Achilles Therapeutics plc)|cargo-tx.com (CRGX) - Kacepetan wutah bathi saben saham ing taun lumaku|PSTX: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku TSVT (2seventy bio Inc.)